A recent meta-analysis showed that mTORi improved overall survival but did not reach statistical significance in HCC recurrence in LT recipients 30 .
← all excerpts
Cumulative exposure to tacrolimus during early period after liver transplantation does not affect the recurrence of hepatocellular carcinoma.
1
—
—